ERHARDT, ELVIRA MARIA
ERHARDT, ELVIRA MARIA
Mostra
records
Risultati 1 - 4 di 4 (tempo di esecuzione: 0.012 secondi).
Bayesian and Stochastic Techniques for Mixed Effects Models in Early Phase Drug Development
2019-07-01
Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: Data from the SENSCIS trial
2023-01-01 Denton C.P.; Goh N.S.; Humphries S.M.; Maher T.M.; Spiera R.; Devaraj A.; Ho L.; Stock C.; Erhardt E.; Alves M.; Wells A.U.
Nintedanib in children and adolescents with fibrosing interstitial lung diseases
2023-01-01 Deterding R.; Young L.R.; DeBoer E.M.; Warburton D.; Cunningham S.; Schwerk N.; Flaherty K.R.; Brown K.K.; Dumistracel M.; Erhardt E.; Bertulis J.; Gahlemann M.; Stowasser S.; Griese M.
Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis
2018-01-01 Burrello, Jacopo; Erhardt, Elvira M; Saint-Hilary, Gaelle; Veglio, Franco; Rabbia, Franco; Mulatero, Paolo; Monticone, Silvia; D'Ascenzo, Fabrizio
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Bayesian and Stochastic Techniques for Mixed Effects Models in Early Phase Drug Development | 2019 | - | |
| Extent of fibrosis and lung function decline in patients with systemic sclerosis and interstitial lung disease: Data from the SENSCIS trial | 2023 | Denton C.P.; Goh N.S.; Humphries S.M.; Maher T.M.; Spiera R.; Devaraj A.; Ho L.; Stock C.; Erhardt E.; Alves M.; Wells A.U. | |
| Nintedanib in children and adolescents with fibrosing interstitial lung diseases | 2023 | Deterding R.; Young L.R.; DeBoer E.M.; Warburton D.; Cunningham S.; Schwerk N.; Flaherty K.R.; Brown K.K.; Dumistracel M.; Erhardt E.; Bertulis J.; Gahlemann M.; Stowasser S.; Griese M. | |
| Pharmacological Treatment of Arterial Hypertension in Children and Adolescents: A Network Meta-Analysis | 2018 | Burrello, Jacopo; Erhardt, Elvira M; Saint-Hilary, Gaelle; Veglio, Franco; Rabbia, Franco; Mulatero, Paolo; Monticone, Silvia; D'Ascenzo, Fabrizio |